COMMUNIQUÉS West-GlobeNewswire

Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
Daix (France), New York City (New York, United States), December 17, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare
17/12/2025
Daix (France), New York City (New York, États-Unis ), le 17 décembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
New Ebook Offers First-Time Biotech CEOs a Roadmap for the Decisions That Determine Company Success
17/12/2025
Produced by KreaMedica, in partnership with Venture Valuation and Lacerta Bio: three leading advisors to early-stage biotechs MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Three of the biotech industry’s trusted advisory [...]
BioNTX Celebrates 2025 Rising Stars Driving North Texas’ Life Science Innovation
17/12/2025
Plano, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- As 2025 comes to a close, BioNTX reflects on a year of innovation, growth, and achievement across North Texas’ life science ecosystem, highlighted by the accomplishments [...]
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
17/12/2025
No Shareholder Action Required at This Time BETHLEHEM, Pa., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and [...]
DeLorean AI Releases New Cardiovascular AI White Paper Showing Predictive AI Can Prevent Heart Failure and Cut Costs by Up to $350,000 Per Patient
17/12/2025
Clinically validated platform delivers predictive precision, empowering clinicians with real-time visibility to reduce preventable complications and improve patient outcomes PALM BEACH, Fla., Dec. 17, 2025 (GLOBE [...]
Transparency Notification from Shareholders
17/12/2025
Ghent, Belgium, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from Shareholders PRESS RELEASE REGULATED INFORMATION 17 December 2025, 6:00 pm CET Ghent, Belgium – 17 December 2025 – Sequana Medical NV ( [...]
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
17/12/2025
LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader [...]
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours
17/12/2025
On track for initial clinical data in mid-2026 Marks a pivotal step toward scalable, accessible, off-the-shelf cell therapies for solid tumours Oslo, Norway, 17 December 2025 – Zelluna (OSE: ZLNA), a company pioneering [...]
Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy
17/12/2025
First-of-its-kind semi-synthetic vitamin E product enables scalable, FDA-compliant production of Peptinovo’s proprietary cancer prodrugs ANN ARBOR, Mich., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Peptinovo Biopharma, an Ann [...]
Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
17/12/2025
BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Acentra Health Appoints President and Chief Operations Officer Meghan Harris to Its Board of Directors
17/12/2025
Long-time healthcare operations leader brings strategic insight, client-first vision, and operational excellence to board role MCLEAN, Va., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health [...]
Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock
17/12/2025
EMERYVILLE, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX) (“Kyverna”), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune [...]
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
17/12/2025
Planned Review of Standard Deviation Demonstrates No Need to Increase Size of Ongoing LEVEL Study LEVEL On Track to Complete Enrollment in First Half of 2026; Topline Data Expected in Second Half of 2026 Global Phase 3 [...]
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
17/12/2025
Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain PHOENIX, Dec. 17, 2025 (GLOBE [...]
SafeSpace Global Corporation (OTCID: SSGC) Appoints Harvest Communications as Investor Relations and Corporate Communications Consulting Agency
17/12/2025
Knoxville, TN, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC), an AI technology company dedicated to protecting lives across education, healthcare, transportation, and correctional [...]
Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy
17/12/2025
The patent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to female patients with sexual dysfunction in order to increase sexual quality of [...]
Population Health Partners and dacadoo Announce Strategic Partnership to Advance Digital Health Engagement and Outcome-Based Healthcare
17/12/2025
New York and Zurich, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Population Health Partners , L.P., a global investor in people and technologies that generate health span and superior returns, and dacadoo , a global leader in [...]
Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell
17/12/2025
RESEARCH TRIANGLE PARK, N.C., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of [...]

Pages